These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. GP IIb-IIIa inhibitors administered upstream: evidence for improved outcomes with conventional and newer antithrombotic agents? Tricoci P; Newby LK Cardiol Rev; 2008; 16(2):89-94. PubMed ID: 18281911 [TBL] [Abstract][Full Text] [Related]
5. Optimizing antiplatelet therapy for the ACS patient: reacting to clinical trial data from the ISAR-REACT-2 studies. Steinhubl SR Rev Cardiovasc Med; 2006; 7 Suppl 4():S12-9. PubMed ID: 17224886 [TBL] [Abstract][Full Text] [Related]
6. The emerging role of platelet glycoprotein IIb/IIIa inhibitors in managing high-risk patients with non-ST segment elevation acute coronary syndromes. Bolognese L Curr Med Res Opin; 2007 Jun; 23(6):1217-26. PubMed ID: 17559721 [TBL] [Abstract][Full Text] [Related]
7. The expanding role of antiplatelet agents in coronary artery disease. A current review of aspirin, glycoprotein IIb/IIIa inhibitors, and the thienopyridines. Hostetter JC; Bhatt DL Minerva Cardioangiol; 2003 Oct; 51(5):531-46. PubMed ID: 14551522 [TBL] [Abstract][Full Text] [Related]
8. What Role for Glycoprotein IIb/IIIa Inhibition in Contemporary Coronary Intervention? Lincoff AM JACC Cardiovasc Interv; 2015 Oct; 8(12):1583-5. PubMed ID: 26493251 [No Abstract] [Full Text] [Related]
16. Antiplatelet therapy in early management of non-ST-segment elevation acute coronary syndrome: the 2002 and 2007 guidelines from North America and Europe. Thomas D; Giugliano RP J Cardiovasc Pharmacol; 2008 May; 51(5):425-33. PubMed ID: 18418272 [TBL] [Abstract][Full Text] [Related]
17. Drug therapy during percutaneous coronary interventions in stable and unstable coronary artery disease: the Italian Drug Evaluation in Angioplasty (IDEA) study. Savonitto S; Ambrosini V; Marzocchi A; Tolaro S; Petronio AS; Galassi AR; Bongo AS; Gaglione A; Bolognese L; ; Ital Heart J; 2005 Feb; 6(2):106-18. PubMed ID: 15819503 [TBL] [Abstract][Full Text] [Related]
18. Antithrombotic therapy and the transition to the catheterization laboratory in UA/NSTEMI. Ferguson JJ; Wilson JM; Diez J Minerva Cardioangiol; 2007 Oct; 55(5):529-56. PubMed ID: 17912162 [TBL] [Abstract][Full Text] [Related]
19. The role of platelet glycoprotein IIb/IIIa antagonists in percutaneous coronary revascularization procedures. Dangas G; Fuster V Rev Port Cardiol; 1999 Feb; 18 Suppl 1():I49-53. PubMed ID: 10191675 [TBL] [Abstract][Full Text] [Related]
20. Advances in antiplatelet therapy for ACS and PCI. Moliterno DJ J Interv Cardiol; 2008 Dec; 21 Suppl 1():S18-24. PubMed ID: 19090933 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]